EXPAREL
NDC 65250-266, bupivacaine, injection, suspension, liposomal, from Pacira Pharmaceuticals, Inc..
- Product NDC
- 65250-266
- Status
- Listed
- Labeler
- Pacira Pharmaceuticals, Inc.
- Dosage form
- INJECTION, SUSPENSION, LIPOSOMAL
- Route
- INFILTRATION
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022496
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65250-266 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPIVACAINE13.3 mg/mL
Pharmacologic classes
Amide Local Anesthetic [EPC]; Amides [CS]; Local Anesthesia [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65250-266-04 | 65250026604 | 4 VIAL in 1 CARTON (65250-266-04) / 20 mL in 1 VIAL (65250-266-20) |
| 65250-266-09 | 65250026609 | 10 VIAL in 1 CARTON (65250-266-09) / 20 mL in 1 VIAL (65250-266-20) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/bb5a9e59-0f51-11df-8a39-0800200c9a66Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=65250-266
Use it
Look up 65250-266 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65250-266 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65250-266. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.